Janke, F.; Bozorgmehr, F.; Wrenger, S.; Dietz, S.; Heussel, C.P.; Heussel, G.; Silva, C.F.; Rheinheimer, S.; Feisst, M.; Thomas, M.;
et al. Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages. Cancers 2020, 12, 954.
https://doi.org/10.3390/cancers12040954
AMA Style
Janke F, Bozorgmehr F, Wrenger S, Dietz S, Heussel CP, Heussel G, Silva CF, Rheinheimer S, Feisst M, Thomas M,
et al. Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages. Cancers. 2020; 12(4):954.
https://doi.org/10.3390/cancers12040954
Chicago/Turabian Style
Janke, Florian, Farastuk Bozorgmehr, Sabine Wrenger, Steffen Dietz, Claus P. Heussel, Gudula Heussel, Carlos F. Silva, Stephan Rheinheimer, Manuel Feisst, Michael Thomas,
and et al. 2020. "Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages" Cancers 12, no. 4: 954.
https://doi.org/10.3390/cancers12040954
APA Style
Janke, F., Bozorgmehr, F., Wrenger, S., Dietz, S., Heussel, C. P., Heussel, G., Silva, C. F., Rheinheimer, S., Feisst, M., Thomas, M., Golpon, H., Günther, A., Sültmann, H., Muley, T., Janciauskiene, S., Meister, M., & Schneider, M. A.
(2020). Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages. Cancers, 12(4), 954.
https://doi.org/10.3390/cancers12040954